Sorrento Therapeutics, Inc. ( SRNE) - Stock Earnings
Stock symbol SRNE is outdated, potentially delisted? Maybe it is available on other exchange?
SRNE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q1 | -40.8 million USD | 18.4 million USD |
| 2022Q2 | -218.8 million USD | 11.5 million USD |
| 2022Q3 | -89.6 million USD | 17.4 million USD |
SRNE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2019 | -292.1 million USD | 31.4 million USD |
| 2020 | -298.5 million USD | 40.0 million USD |
| 2021 | -428.3 million USD | 52.9 million USD |
SRNE
Price: $0.31
52 week price:
Earnings Per Share: -0.68 USD
P/E Ratio: -4.43
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 9.3 million
Ebitda: 98.2 millionMarket Capitalization: 168.4 million